This episode of "This Week in Virology" features an in-depth interview with Dr. Stanley Plotkin, a legendary vaccinologist who recounts his extensive career and offers his perspective on the current state of public health and vaccinology. Dr. Plotkin discusses his early inspirations, including his time at the Bronx High School of Science, and details his foundational work on several major vaccines. He shares his experiences developing an oral polio vaccine alongside Hilary Koprowski, his pivotal development of the RA27/3 rubella vaccine using WI-38 human diploid cells to combat congenital rubella syndrome, and his role in advancing the modern rabies vaccine. Dr. Plotkin also reflects on his long-standing "dream" of creating a cytomegalovirus (CMV) vaccine, outlining the biological complexities that have made it a persistent challenge.
Beyond his historical contributions, Dr. Plotkin expresses deep concern over the contemporary anti-science and anti-vaccine climate, attributing it to failures in early-childhood science education and the proliferation of misinformation. He critiques current public health strategies, advocates for a global shift to the inactivated polio vaccine (IPV), and discusses the scientific and market hurdles for vaccines against pathogens like West Nile virus and HIV, identifying mucosal immunity as a key frontier in vaccine development.
A Conversation with a Vaccine Pioneer: Dr. Stanley Plotkin's Career and Insights
1:53 Early Influences and Education: Dr. Plotkin recounts growing up in New York City, attending the Bronx High School of Science, and being profoundly inspired to pursue a career in medical research after reading Arrowsmith and Microbe Hunters as a teenager.
15:25 Polio Vaccine Development: He describes his work in Hilary Koprowski's lab on an attenuated oral polio vaccine, which competed with Albert Sabin's strains. This early work gave him hands-on experience in virology and vaccine attenuation.
22:12 Modern Polio Eradication Strategy: Dr. Plotkin argues that the global polio eradication strategy should now shift from the live oral polio vaccine (OPV) to the inactivated polio vaccine (IPV) as much as possible to eliminate the risk of vaccine-associated paralytic polio.
24:53 Creating the Rubella Vaccine: Motivated by the devastating 1960s rubella epidemic, Dr. Plotkin developed the highly successful RA27/3 vaccine. He made the then-controversial choice to attenuate the virus in WI-38 human diploid cells, which he believed was a safer substrate.
38:26 Rubella Elimination Status: He notes that while rubella is largely eliminated from the Western Hemisphere and Europe, it remains a public health challenge in parts of Asia and Africa that lack comprehensive vaccination coverage.
43:58 The Lifelong Pursuit of a CMV Vaccine: Dr. Plotkin details his decades-long effort to develop a vaccine for cytomegalovirus (CMV), a major cause of birth defects. He explains the biological complexities of the virus, such as latency and the need for a strong cellular immune response, which have made vaccine development difficult.
52:22 Advancing the Rabies Vaccine: He shares his experience conducting clinical trials for a new rabies vaccine in veterinary students, work that helped establish the modern, highly effective, and far less arduous post-exposure prophylaxis regimen used today.
59:44 West Nile Virus as an "American Disease": Dr. Plotkin highlights that West Nile virus is now endemic in the US and believes a vaccine is scientifically feasible. The primary hurdle, he suggests, is the lack of a clear commercial market to incentivize its development.
1:06:23 Diagnosing the Anti-Vaccine Movement: He expresses horror at the current anti-science sentiment and the dismantling of the public health apparatus. He argues the root cause is a failure of the education system to teach critical thinking and scientific evaluation from grade school onward.
1:30:12 A Grim Prediction for Public Health: Echoing a sentiment from Maurice Hilleman, Dr. Plotkin fears that it may take the re-emergence of deadly diseases and a significant number of child deaths to reverse the current anti-vaccine trend.
1:42:04 The Next Frontier in Vaccinology: Dr. Plotkin identifies the induction of robust and durable mucosal immunity as the biggest unsolved problem in vaccine development. He believes solving this is critical for creating effective vaccines against challenging pathogens like HIV and other sexually transmitted or respiratory viruses.